Suppr超能文献

儿童结核病的多药耐药趋势与挑战。

Trends and challenges of multi-drug resistance in childhood tuberculosis.

机构信息

Chinese Academy of Sciences (CAS) Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.

出版信息

Front Cell Infect Microbiol. 2023 Jun 2;13:1183590. doi: 10.3389/fcimb.2023.1183590. eCollection 2023.

Abstract

Drug-resistant tuberculosis (DR-TB) in children is a growing global health concern, This review provides an overview of the current epidemiology of childhood TB and DR-TB, including prevalence, incidence, and mortality. We discuss the challenges in diagnosing TB and DR-TB in children and the limitations of current diagnostic tools. We summarize the challenges associated with treating multi-drug resistance TB in childhood, including limitations of current treatment options, drug adverse effects, prolonged regimens, and managing and monitoring during treatment. We highlight the urgent need for improved diagnosis and treatment of DR-TB in children. The treatment of children with multidrug-resistant tuberculosis will be expanded to include the evaluation of new drugs or new combinations of drugs. Basic research is needed to support the technological development of biomarkers to assess the phase of therapy, as well as the urgent need for improved diagnostic and treatment options.

摘要

儿童耐多药结核病(DR-TB)是一个日益严重的全球卫生关注问题。本文综述了儿童结核病和耐多药结核病的当前流行病学,包括患病率、发病率和死亡率。我们讨论了儿童结核病和耐多药结核病诊断方面的挑战,以及当前诊断工具的局限性。我们总结了与儿童耐多药结核病治疗相关的挑战,包括当前治疗方案的局限性、药物不良反应、延长疗程以及治疗期间的管理和监测。我们强调了迫切需要改善儿童耐多药结核病的诊断和治疗。将扩大儿童耐多药结核病的治疗范围,包括评估新的药物或新的药物组合。需要开展基础研究,以支持治疗阶段的生物标志物评估技术的发展,同时迫切需要改进诊断和治疗选择。

相似文献

1
Trends and challenges of multi-drug resistance in childhood tuberculosis.儿童结核病的多药耐药趋势与挑战。
Front Cell Infect Microbiol. 2023 Jun 2;13:1183590. doi: 10.3389/fcimb.2023.1183590. eCollection 2023.
6
Tuberculosis in childhood.儿童结核病。
Ther Adv Respir Dis. 2012 Jun;6(3):161-71. doi: 10.1177/1753465812436662. Epub 2012 Feb 23.
8
The Global Landscape of Tuberculosis Therapeutics.全球结核病治疗学全景
Annu Rev Med. 2019 Jan 27;70:105-120. doi: 10.1146/annurev-med-040717-051150. Epub 2018 Nov 7.
10
Isoniazid-resistant tuberculosis: a cause for concern?耐异烟肼结核病:值得关注的一个原因?
Int J Tuberc Lung Dis. 2017 Feb 1;21(2):129-139. doi: 10.5588/ijtld.16.0716.

引用本文的文献

本文引用的文献

1
Biomarker discovery for tuberculosis using metabolomics.使用代谢组学发现结核病生物标志物。
Front Mol Biosci. 2023 Feb 20;10:1099654. doi: 10.3389/fmolb.2023.1099654. eCollection 2023.
2
Treatment options for children with multi-drug resistant tuberculosis.耐多药结核病患儿的治疗选择。
Expert Rev Clin Pharmacol. 2023 Jan;16(1):5-15. doi: 10.1080/17512433.2023.2148653. Epub 2022 Nov 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验